Table 1 Recipients characteristics of patients with class I/II panel reactive antibody < 50% and ≥50%
|  | All recipients (n = 76) | PRA < 50% (n = 67) | PRA ≥ 50% (n = 9) | p-value |
|---|---|---|---|---|
Age, median (range), yrs | 52.0 (17–75) | 53.0 (18–75) | 44.0 (17–52) | 0.013 |
Male, n (%) | 42 (55.3) | 39 (58.2) | 3 (33.3) | 0.284 |
BMI, median (IQR), kg/m2 | 19.1 (17.4–21.6) | 19.0 (17.4–21.6) | 19.8 (16.1–21.6) | 0.981 |
ABO, n (%) | Â | Â | Â | 0.413 |
 A | 26 (34.2) | 24 (35.8) | 2 (22.2) |  |
 B | 26 (34.2) | 23 (34.3) | 3 (33.3) |  |
 AB | 6 (7.9) | 4 (6.0) | 2 (22.2) |  |
 O | 18 (23.7) | 16 (23.9) | 2 (22.2) |  |
Primary diagnosis, n (%) | Â | Â | Â | 0.277 |
 COPD/emphysema | 4 (5.3) | 3 (4.5) | 1 (11.1) |  |
 IPF | 37 (48.7) | 35 (52.2) | 2 (22.2) |  |
 IPAH | 1 (1.3) | 1 (1.5) | 0 (0) |  |
 IIP other than IPF* | 3 (3.9) | 2 (3.0) | 1 (11.1) |  |
 Bronchiectasis/ destroyed lung by TB | 4 (5.3) | 4 (6.0) | 0 (0) |  |
 BOS after HSCT | 11 (14.5) | 9 (14.9) | 2 (22.2) |  |
 Interstitial lung disease related with CTD | 5 (6.6) | 4 (6.0) | 1 (11.1) |  |
 LAM | 9 (11.8) | 7 (10.4) | 2 (22.2) |  |
 Others** | 2 (2.6) | 2 (3.0) | 0 (0) |  |
Smoking, n (%) | Â | Â | Â | 0.141 |
 Smoker | 30 (39.5) | 29 (43.3) | 1 (11.1) |  |
   ≥ 20 pack-years | 22 (28.9) | 21 (31.3) | 1 (11.1) |  |
   < 20 pack-years | 8 (10.6) | 8 (12.0) | 0 (0) |  |
  Never smoker | 46 (60.5) | 38 (56.7) | 8 (88.9) |  |
Bilateral lung transplantation, n (%) | 62 (81.6) | 53 (79.1) | 9 (100) | 0.197 |